Literature DB >> 28619900

Deciphering microglial diversity in Alzheimer's disease.

Guy C Brown1, Peter H St George-Hyslop2,3.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28619900     DOI： 10.1126/science.aan7893

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  9 in total

Review 1.  Alzheimer's Disease-Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran.

Authors:  Klaus Grossmann
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

Review 2.  ApoE4: an emerging therapeutic target for Alzheimer's disease.

Authors:  Mirna Safieh; Amos D Korczyn; Daniel M Michaelson
Journal:  BMC Med       Date:  2019-03-20       Impact factor: 8.775

3.  Computational Studies Applied to Flavonoids against Alzheimer's and Parkinson's Diseases.

Authors:  Alex France M Monteiro; Jéssika De O Viana; Anuraj Nayarisseri; Ernestine N Zondegoumba; Francisco Jaime B Mendonça Junior; Marcus Tullius Scotti; Luciana Scotti
Journal:  Oxid Med Cell Longev       Date:  2018-12-30       Impact factor: 6.543

Review 4.  Molecular Insight into the Therapeutic Promise of Targeting APOE4 for Alzheimer's Disease.

Authors:  Abdullah Al Mamun; Md Sahab Uddin; Md Fahim Bin Bashar; Sonia Zaman; Yesmin Begum; Israt Jahan Bulbul; Md Siddiqul Islam; Md Shahid Sarwar; Bijo Mathew; Md Shah Amran; Ghulam Md Ashraf; May N Bin-Jumah; Shaker A Mousa; Mohamed M Abdel-Daim
Journal:  Oxid Med Cell Longev       Date:  2020-05-15       Impact factor: 6.543

Review 5.  Decoding Mast Cell-Microglia Communication in Neurodegenerative Diseases.

Authors:  Jagdeep K Sandhu; Marianna Kulka
Journal:  Int J Mol Sci       Date:  2021-01-22       Impact factor: 5.923

Review 6.  Perspectives on the Role of APOE4 as a Therapeutic Target for Alzheimer's Disease.

Authors:  Kavita Patel; Siwangi Srivastava; Shikha Kushwah; Ashutosh Mani
Journal:  J Alzheimers Dis Rep       Date:  2021-12-27

Review 7.  Direct Oral Anticoagulants (DOACs) for Therapeutic Targeting of Thrombin, a Key Mediator of Cerebrovascular and Neuronal Dysfunction in Alzheimer's Disease.

Authors:  Klaus Grossmann
Journal:  Biomedicines       Date:  2022-08-04

Review 8.  Clinical PET Imaging of Microglial Activation: Implications for Microglial Therapeutics in Alzheimer's Disease.

Authors:  Zhiwei Shen; Xinjie Bao; Renzhi Wang
Journal:  Front Aging Neurosci       Date:  2018-10-08       Impact factor: 5.750

Review 9.  APOE2: protective mechanism and therapeutic implications for Alzheimer's disease.

Authors:  Zonghua Li; Francis Shue; Na Zhao; Mitsuru Shinohara; Guojun Bu
Journal:  Mol Neurodegener       Date:  2020-11-04       Impact factor: 18.879
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.